Medtronic funding a Phase I trial evaluating Nile Therapeutic's cenderitide (formerly CD-NP) delivered through Medtronic's diabetes pump technology for heart failure

Nile Therapeutics Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Medtronic Inc.

U.S. / Medical Devices and Diagnostics

Investor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced